Press Releases from DelveInsight Business Research LLP (2463 total)
Hemophilia A Market is Expected to Show a Healthy Growth Rate During the Study P …
(Las Vegas, Nevada, United States) "Hemophilia A- Market Insights, Epidemiology and Market Forecast- 2032" by DelveInsight provides a comprehensive analysis of Hemophilia A, including a detailed examination of its historical and projected Hemophilia A epidemiology. Additionally, the report offers insights into the Hemophilia A market trends in the United States, EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan, aiming to enhance the understanding of this condition.
Download Sample…
Lewy Body Disease Pipeline Assessment (2023) Covering Clinical Trials, Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Lewy Body Disease therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Lewy Body Disease Pipeline Insight, 2023" report…
Biliary Tract Cancers Pipeline Assessment (2023) Covering Clinical Trials, Emerg …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 80+ key pharma and biotech companies are working on 80+ pipeline drugs in the Biliary Tract Cancers therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Biliary Tract Cancers Pipeline Insight, 2023" report…
Acute Kidney Injury Pipeline Assessment (2023) Covering Clinical Trials, Emergin …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Acute Kidney Injury therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Acute Kidney Injury Pipeline Insight, 2023" report…
Adenoid Cystic Carcinoma Pipeline Assessment (2023) Covering Clinical Trials, Em …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Adenoid Cystic Carcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Adenoid Cystic Carcinoma Pipeline Insight,…
Borderline Personality Disorders Pipeline Assessment (2023) Covering Clinical Tr …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Borderline Personality Disorders therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Borderline Personality Disorders Pipeline Insight, 2023" report…
Efgartigimod Emerging Drug Insight and Market Forecast 2032 | DelveInsight
(Las Vegas, Nevada, United States), The "Efgartigimod Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about efgartigimod for thrombocytopenia in the seven major markets. A detailed picture of the efgartigimod for thrombocytopenia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, and Japan for the study period 2019 -2032 is provided in this report along with a detailed…
Brescap Emerging Drug Insight and Market Forecast 2032 | DelveInsight
(Las Vegas, Nevada, United States), "bRESCAP Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about bRESCAP for Acute Kidney Injury (AKI) in the seven major markets. A detailed picture of the bRESCAP for AKI in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 -2032 is provided in this report along with…
AXS14 Emerging Drug Insight and Market Forecast 2032 | DelveInsight
(Las Vegas, Nevada, United States), The "AXS-14 Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about AXS-14 for chronic pain in the seven major markets. A detailed picture of the AXS-14 for chronic pain in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 -2032 is provided in this report along with…
Ilofotase alfa Emerging Drug Insight and Market Forecast 2032 | DelveInsight
(Las Vegas, Nevada, United States), "Ilofotase alfa Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about ilofotase alfa for Acute Kidney Injury (AKI) in the seven major markets. A detailed picture of the ilofotase alfa for AKI in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 -2032 is provided in this…
EscharEx Emerging Drug Insight and Market Forecast 2032 | DelveInsight
(Las Vegas, Nevada, United States), "EscharEx Emerging Drug Insight and Market Forecast - 2032" report provides comprehensive insights about EscharEx for chronic wounds in the seven major markets. A detailed picture of the EscharEx for chronic wounds in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 -2032 is provided in this report along with a…
Diabetic Macular Edema Pipeline Assessment (2023) Covering Clinical Trials, Emer …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 60+ key pharma and biotech companies are working on 65+ pipeline drugs in the Diabetic Macular Edema therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Diabetic Macular Edema Pipeline Insight,…
Cirrhosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapie …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Cirrhosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Cirrhosis Pipeline Insight, 2023" report by DelveInsight…
Urinary Tract Infections Pipeline Assessment (2023) Covering Clinical Trials, Em …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 38+ key pharma and biotech companies are working on 38+ pipeline drugs in the Urinary Tract Infections therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Urinary Tract Infections Pipeline Insight,…
Multiple Myeloma Pipeline Assessment (2023) Covering Clinical Trials, Emerging T …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 100+ key pharma and biotech companies are working on 130+ pipeline drugs in the Multiple Myeloma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Multiple Myeloma Pipeline Insight, 2023" report…
Focal Segmental Glomerulosclerosis (FSGS) Pipeline Assessment (2023) Covering Cl …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 18+ pipeline drugs in the Focal Segmental Glomerulosclerosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Focal Segmental Glomerulosclerosis (FSGS) Pipeline…
Graves' Disease Pipeline Assessment (2023) Covering Clinical Trials, Emerging Th …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 10+ pipeline drugs in the Graves' Disease therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Graves' Disease Pipeline Insight, 2023" report…
Meibomian Gland Dysfunction Pipeline Assessment (2023) Covering Clinical Trials, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Meibomian Gland Dysfunction therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Meibomian Gland Dysfunction Pipeline Insight,…
Skin Burns Market to Witness Growth During the Forecast Period (2023-32), Estima …
(Las Vegas, Nevada, United States), DelveInsight's "Skin Burns Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Skin Burns, historical and forecasted epidemiology as well as the Skin Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Skin Burns Overview
A burn is an injury to the skin or other organic tissue primarily caused by heat or due to…
Chronic Myelomonocytic Leukaemia Pipeline Assessment (2023) Covering Clinical Tr …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Chronic Myelomonocytic Leukaemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Chronic Myelomonocytic Leukaemia Pipeline Insight,…
Methylmalonic Acidemia Pipeline Assessment (2023) Covering Clinical Trials, Emer …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Methylmalonic Acidemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Methylmalonic Acidemia Pipeline Insight, 2023" report…
Myocardial Infarction Pipeline Assessment (2023) Covering Clinical Trials, Emerg …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 60+ key pharma and biotech companies are working on 60+ pipeline drugs in the Myocardial Infarction therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Myocardial Infarction Pipeline Insight, 2023" report…
Uromune (MV140) Drug Market Forecast and Analysis | Uromune (MV140) for uncompli …
(Albany, United States)//- The Uromune (MV140) market forecast report provides an analysis of the Uromune (MV140) market analysis and forecasts up to 2032 in the seven major markets (7MM). The comprehensive report provides an analysis of Uromune (MV140) market potential and Uromune (MV140) market share analysis in uncomplicated Urinary Tract Infection across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan from 2019 to 2032.…
GSK2140944 (Gepotidacin) Drug Market Forecast and Analysis | GSK2140944 (Gepotid …
(Albany, United States)//- The GSK2140944 (Gepotidacin) market forecast report provides an analysis of the GSK2140944 (Gepotidacin) market analysis and forecasts up to 2032 in the seven major markets (7MM). The comprehensive report provides an analysis of GSK2140944 (Gepotidacin) market potential and GSK2140944 (Gepotidacin) market share analysis in uncomplicated Urinary Tract Infection across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan from 2019 to 2032.…
Sulopenem Etzadroxil/Probenecid Drug Market Forecast and Analysis | Sulopenem Et …
(Albany, United States)//- The Sulopenem Etzadroxil/Probenecid market forecast report provides an analysis of the Sulopenem Etzadroxil/Probenecid market analysis and forecasts up to 2032 in the seven major markets (7MM). The comprehensive report provides an analysis of Sulopenem Etzadroxil/Probenecid market potential and Sulopenem Etzadroxil/Probenecid market share analysis in uncomplicated Urinary Tract Infection across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan from 2019 to 2032.…
Psoriatic Arthritis Market to Witness Growth by 2032, Estimates DelveInsight | C …
DelveInsight's "Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Psoriatic Arthritis, historical and forecasted epidemiology as well as the Psoriatic Arthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Psoriatic Arthritis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Psoriatic Arthritis market size…
Inflammatory Bowel Disease market to Witness Growth by 2032 | Companies- Eli Lil …
DelveInsight's "Inflammatory Bowel Disease market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Inflammatory bowel disease, historical and forecasted epidemiology as well as the Inflammatory Bowel Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Inflammatory Bowel Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Congenital Ichthyosis Pipeline Assessment (2023) Covering Clinical Trials, Emerg …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on developing various novel drugs in the Congenital Ichthyosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Congenital Ichthyosis Pipeline Insight, 2023" report…
Prurigo Nodularis Pipeline Assessment (2023) Covering Clinical Trials, Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Prurigo Nodularis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Prurigo Nodularis Pipeline Insight, 2023" report…
Hepatic Encephalopathy Market is Expected to Showcase a Significant Growth Durin …
The Hepatic Encephalopathy Market size in the 7MM was USD 1,563 Million in 2021, which is expected to grow by 2032. Hepatic Encephalopathy Market is expected to grow by 2032 owing to the anticipated approval of emerging therapies and the increasing patient population of Hepatic Encephalopathy in the 7MM.
DelveInsight's "Hepatic Encephalopathy Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology,…
Dry Age-Related Macular Degeneration (Dry AMD) Market is Predicted to Exhibit Re …
The Dry Age-Related Macular Degeneration (Dry AMD) Market size in the seven major markets was estimated to be USD 1,377 million in 2021. As per DelveInsight, the Dry Age-Related Macular Degeneration Market is anticipated to evolve immensely in the coming years owing to the rise in the number of prevalent cases of Dry AMD in the 7MM, the improvement in the diagnosis methodologies, raising awareness of the disease, incremental…
Plaque Psoriasis Market to Register Incremental Growth During the Forecast Perio …
As per DelveInsight, the Plaque Psoriasis Market is anticipated to evolve immensely in the coming years owing to the launch of new therapies, the increased number of Plaque Psoriasis cases, the rising awareness to treat localized disease, and a better understanding of disease pathogenesis, globally. Companies such as Soligenix, Dermavant Sciences, Lipidor AB, etc., are some of the key players involved in developing therapies for plaque psoriasis.
DelveInsight's "Plaque Psoriasis Market…
Thrombotic Thrombocytopenic Purpura Pipeline Assessment (2023) Covering Clinical …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 5+ key pharma and biotech companies are working on 5+ pipeline drugs in the Thrombotic Thrombocytopenic Purpura therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Thrombotic Thrombocytopenic Purpura Pipeline Insight,…
Papulopustular Rosacea Pipeline Assessment (2023) Covering Clinical Trials, Emer …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Papulopustular Rosacea therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Papulopustular Rosacea Pipeline Insight, 2023" report…
Myopia Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 12+ pipeline drugs in the Myopia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Myopia Pipeline Insight, 2023" report by DelveInsight…
Endometriosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Ther …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 18+ key pharma and biotech companies are working on 25+ pipeline drugs in the Endometriosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Endometriosis Pipeline Insight, 2023" report by DelveInsight…
Aneurysmal Subarachnoid Hemorrhage (aSAH) Pipeline Assessment (2023) Covering Cl …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 8+ key pharma and biotech companies are working on 10+ pipeline drugs in the Aneurysmal Subarachnoid Hemorrhage therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Aneurysmal Subarachnoid Hemorrhage (aSAH) Pipeline…
Marginal Zone Lymphoma Pipeline Assessment (2023) Covering Clinical Trials, Emer …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Marginal Zone Lymphoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Marginal Zone Lymphoma Pipeline Insight,…
Friedreich's Ataxia Pipeline Assessment (2023) Covering Clinical Trials, Emergin …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Friedreich's Ataxia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Friedreich's Ataxia Pipeline Insight, 2023" report…
Spinal Muscular Atrophy Pipeline Assessment (2023) Covering Clinical Trials, Eme …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 18+ key pharma and biotech companies are working on 20+ pipeline drugs in the Spinal Muscular Atrophy therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Spinal Muscular Atrophy Pipeline Insight,…
Lupus Nephritis Pipeline Assessment (2023) Covering Clinical Trials, Emerging Th …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Lupus Nephritis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Lupus Nephritis Pipeline Insight, 2023" report…
Pediatric Growth Hormone Deficiency (PGHD) Market to Grow at a Substantial Growt …
DelveInsight's "Pediatric Growth Hormone Deficiency (PGHD) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Pediatric Growth Hormone Deficiency Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).
The market report covers emerging drugs, treatment practices, market share of individual Pediatric Growth…
Weight Loss/Weight Management (Obesity) Market to Register Incremental Growth Du …
As per DelveInsight, the Weight Loss/Weight Management (Obesity) Market is anticipated to evolve immensely in the coming years owing to the increase in upcoming novel treatment options, rising prevalence, and increasing global healthcare investment and funding.
DelveInsight's "Weight Loss/Weight Management (Obesity) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Weight Loss/Weight Management Market Size and Share…
Limb Girdle Muscular Dystrophy (LGMD) Pipeline Assessment (2023) Covering Clinic …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 25+ pipeline drugs in the Limb Girdle Muscular Dystrophy (LGMD) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Limb Girdle Muscular…
Liver Fibrosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging The …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Liver Fibrosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Liver Fibrosis Pipeline Insight, 2023" report…
Liver Fibrosis Pipeline Assessment (2023) Covering Clinical Trials, Emerging The …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Liver Fibrosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Liver Fibrosis Pipeline Insight, 2023" report…
Tourette Syndrome Pipeline Assessment (2023) Covering Clinical Trials, Emerging …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are actively working on developing novel therapies in the Tourette Syndrome therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Tourette Syndrome Pipeline Insight, 2023" report…
Glioma Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 190+ key pharma and biotech companies are working on 130+ pipeline drugs in the Glioma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Glioma Pipeline Insight, 2023" report by DelveInsight…
Lyme Disease Market to Witness Growth by 2032 | Companies- Valneva, Cortene, Blu …
DelveInsight's "Lyme Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Lyme Disease, historical and forecasted epidemiology as well as the Lyme Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Lyme Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Lyme Disease market size…
Lymphoedema Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therap …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Lymphoedema therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Lymphoedema Pipeline Insight, 2023" report by DelveInsight…
